Standard BioTools
LAB
LAB
160 hedge funds and large institutions have $337M invested in Standard BioTools in 2025 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 48 increasing their positions, 45 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
160
Holders Change
+13
Holders Change %
+8.84%
% of All Funds
2.15%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
28
Increased
48
Reduced
45
Closed
13
Calls
$68K
Puts
$49K
Net Calls
+$19K
Net Calls Change
+$75K
Top Buyers
| 1 |
LFCM
Long Focus Capital Management
San Juan,
Puerto Rico
|
$12.1M |
| 2 |
MCO
MAK Capital One
New York
|
$6.72M |
| 3 |
KLP
Kent Lake PR
Anasco,
Puerto Rico
|
$1.2M |
| 4 |
Goldman Sachs
New York
|
$1.58M |
| 5 |
RA
Royce & Associates
New York
|
$3.16M |
Top Sellers
| 1 |
Morgan Stanley
New York
|
$7.47M |
| 2 |
Millennium Management
New York
|
$2.83M |
| 3 |
TM
Tikvah Management
Charlotte,
North Carolina
|
$6.06M |
| 4 |
Primecap Management
Pasadena,
California
|
$347K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
$368K |
